Nov. 24 at 3:24 PM
DarioHealth published a peer-reviewed study showing its digital health platform lowered healthcare costs for diabetes patients. The Journal of Medical Internet Research study found users had 23.5% fewer hospitalizations and 9.3% lower overall healthcare utilization versus matched patients receiving usual care. Conducted by independent researchers from Sanofi and Symphony Health, the analysis compared 2,445 adults with type 2 diabetes using Dario’s platform to 7,334 similar individuals over 12 months, estimating annual gross savings of
$5,077 per patient. Dario’s CMO said the results show digital interventions can cut avoidable hospitalizations and overall care costs. With U.S. diabetes costs exceeding
$300 billion in 2022 and 38 million Americans affected, the company sees a
$31 billion market opportunity.
$DRIO